Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Elastin microfibril interfacer 2 pseudogene (ENSG00000276632) is classified as a processed pseudogene—it is a noncoding genomic locus that resembles a functional gene but contains mutations that prevent translation into a protein[3][1]. Pseudogenes often arise through duplication or retrotransposition and lack the capability to encode a functional protein; they may retain intron-exon structure or have features such as polyA tracts, but generally do not produce biologically active proteins[1]. While some pseudogenes have emerged as regulators of gene expression—acting as sources of small interfering RNAs or as decoys for microRNAs—most remain biologically silent, and there is no published evidence that this particular pseudogene has a specific regulatory or disease function[1][5]. It is not considered a therapeutic target, and does not possess molecular features typical of receptors, enzymes, transporters, or other druggable protein classes. If you require information on a functional protein, receptor, or enzyme, consider searching for the parent gene or a true protein-coding locus rather than this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Elastin microfibril interfacer 2 pseudogene.